Jubilant Pharmova approves up to ₹800 crore NCD issue and seeks ₹2,500 crore debt authorization
As filed · Jubilant Pharmova Limited has informed the Exchange about Issuance of Secured / Unsecured, Listed, Rated, Redeemable Non-Convertible Debentures (NCDs) on Private Placement Basis
What happened
FactJubilant Pharmova’s board approved issuing up to 80,000 secured or unsecured, listed, rated, redeemable NCDs of ₹1,00,000 each, aggregating up to ₹800 crore, through private placement in one or more tranches. The company will seek shareholder approval for non-convertible debt securities with aggregate outstanding amounts of up to ₹2,500 crore at any point during one year from the special resolution.
Why it matters
CapitSignal interpretationRaising capital changes the share count or the debt load, and the stated use of proceeds is a commitment that can later be checked.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
WithdrawnRevenue: ~ 3x of FY24
Expect technology transfer revenues to start in Q4’FY27
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Instrument and amount finally raised
- Stated use of proceeds
- Whether the enabling resolution is actually used
- EBITDA Margin: More than 25% (management committed by FY30)
- Revenue: ~ 3x of FY24 (management committed by FY30)
Evidence
- Jubilant Pharmova Limited has informed the Exchange regarding Outcome of Board Meeting held on October 12, 2026 for the Issuance of Secured / Unsecured, Listed, Rated, Redeemable Non-Convertible Debentures (NCDs) on Private Placement Basis(opens the original filing in a new tab)
- Earlier statement · FY27
- Latest statement · FY27
- Earlier statement · FY27
How CapitSignal classified this
- Reasoning:
- The filing indicates a potential expansion of the company’s debt funding capacity, although the coupon, security terms, and issue timing remain subject to the bidding process and issue documents. Shareholder authorization is still required for the broader ₹2,500 crore outstanding limit.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%